Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-428-0 | CAS number: 120-82-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Not a skin sensitiser in guinea-pigs studies:
1/ Korte & Kreim, 1981
2/ EU RAR / Brown et al., 1969.
3/ EU RAR / Du Pont de Nemours, 1971.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- A series of exposures was given to the male albino guinea-pigs over a three-week intervals; the first five guinea-pigs received nine topical applications of 0.05 mL varying concentrations (50% x 4, 75% x 5) in f.a.d. (13% guinea-pig fat in a 1:1 solution of acetone and dioxane) to clipped abraded skin, and the other five animals received four sacral intradermal injections of 0.1 mL 1% solution v/v of test material in DMP (dimethylphtalate). After a two-week rest period, the test animals were challenged for sensitization by applying 0.05 mL of 75% and 95% (v/v) concentrations to shaved intact shoulder skin. A group of 10 previously unexposed guinea-pigs received similar applications at the time of challenge to provide a direct comparison of the challenge reactions of skin of similar age.
- GLP compliance:
- no
- Type of study:
- not specified
- Justification for non-LLNA method:
- The study pre-dates LLNA method
- Species:
- guinea pig
- Strain:
- not specified
- Remarks:
- Albino
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: N/A
- Microbiological status of animals, when known: N/A
- Age at study initiation: N/A
- Weight at study initiation: 500 g
- Housing: N/A
- Diet (e.g. ad libitum): N/A
- Water (e.g. ad libitum): N/A
- Acclimation period: N/A
- Indication of any skin lesions: N/A
ENVIRONMENTAL CONDITIONS
- Temperature (°C): N/A
- Humidity (%): N/A
- Air changes (per hr): N/A
- Photoperiod (hrs dark / hrs light): N/A
- IN-LIFE DATES: N/A - Route:
- other: epicutaneous, unknown (Group 1)
- Vehicle:
- other: f.a.d
- Concentration / amount:
- 50% x 4, 75% x 5
- Day(s)/duration:
- 9 days
- Adequacy of induction:
- not specified
- Route:
- other: intradermal (Group 2)
- Vehicle:
- other: DMP
- Concentration / amount:
- 1% / 0.1 mL x 4 days
- Day(s)/duration:
- 4 days
- Adequacy of induction:
- not specified
- No.:
- #1
- Route:
- other: epicutaneous, unknown (Group 1 + 2)
- Vehicle:
- other: f.a.d.
- Concentration / amount:
- 75% / 0.05 mL
- Day(s)/duration:
- After a two-week rest period
- Adequacy of challenge:
- not specified
- No.:
- #1
- Route:
- other: epicutaneous, unknown (Group 1 + 2)
- Vehicle:
- other: f.a.d.
- Concentration / amount:
- 95% / 0.05 mL
- Day(s)/duration:
- After a two-week rest period
- Adequacy of challenge:
- not specified
- No. of animals per dose:
- 5 (Group 1) + 5 (Group 2)
- Details on study design:
- Cf. principles of method if other than guideline
- Positive control substance(s):
- no
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 95%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: all 10 animals showed irritant reactions
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 75%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: all 10 animals showed irritant reactions
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test item did not cause skin sensitisation but produced irritation.
- Executive summary:
A series of exposures was given to the male albino guinea-pigs over a three-week intervals; the first five guinea-pigs received nine topical applications of 0.05 mL varying concentrations (50% x 4, 75% x 5) in f.a.d. (13% guinea-pig fat in a 1:1 solution of acetone and dioxane) to clipped abraded skin, and the other five animals received four sacral intradermal injections of 0.1 mL 1% solution v/v of test material in DMP (dimethylphtalate). After a two-week rest period, the test animals were challenged for sensitization by applying 0.05 mL of 75% and 95% (v/v) concentrations to shaved intact shoulder skin. A group of 10 previously unexposed guinea-pigs received similar applications at the time of challenge to provide a direct comparison of the challenge reactions of skin of similar age.
The test item did not cause skin sensitisation but produced irritation.
- Endpoint:
- skin sensitisation
- Type of information:
- other: EU Risk Assessment
- Adequacy of study:
- other information
- Reliability:
- other: EU Risk Assessment
- Rationale for reliability incl. deficiencies:
- other: no reliability is given as this is a summary entry for the EU RAR
- Principles of method if other than guideline:
- EU Risk Assessment
- GLP compliance:
- not specified
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- No GLP. No information about negative control group, and concentration of 1,2,4-TCB. Occlusive bandage during epicutaneous exposure. Detailed results are not reported.
- GLP compliance:
- no
- Remarks:
- GLP was not mandatory at the time of the study
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The GPMT was undertaken pre-introduction of the LLNA (adoption 2002).
- Species:
- guinea pig
- Strain:
- Pirbright-Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Lippische Versuchstierzucht, HAGEMANN GmbH & Co., D-4923 Extertal 1, Germany
- Age at study initiation: 21-28 days
- Weight at study initiation: 250-300g
- Housing: Makrolon- cage (type III)
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 1.0 °C
- Humidity (%): 60% ± 5%
- Photoperiod (hrs dark / hrs light): 12 hrs dark /12 hrs light - Route:
- intradermal and epicutaneous
- Vehicle:
- other: not specified
- Concentration / amount:
- see "Details on study design (traditional tests)"
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: not specified
- Concentration / amount:
- see "Details on study design (traditional tests)"
- No. of animals per dose:
- 20
- Details on study design:
- RANGE FINDING TESTS:
To test the sensitization potential of 1,2,4-trichlorobenzene the maximization procedure was conducted. For this, a preliminary test was conducted on 2-3 animals to delineate any irritating properties of the test substance. The aim was to determine the doses so that, by intradermal administration they arise a skin irritation, by percutaneous application provoke any irritation to the skin.
MAIN STUDY
A. INDUCTION EXPOSURE
INTRADERMAL INJECTIONS: The hair was removed from the back of the animals without injuring the skin. Then an intradermal administration of 0.1 mL of the test substance in an appropriate concentration (0.5-10%) and in appropriate solvent was performed. In addition, the test substance was intradermally applied at the same final concentration and in a mixture of FREUND `S (Bacto Adjuvant, Complete Freund, Fa. Difco Laboratories, Detroit, Michigan, USA) complete Adjuvant, and the solvent (0.1 mL, in the ratio 1 +1). Finally a treatment with intradermal FREUND`S complete Adjuvant plus solvent (0.1 mL in proportion 1+1) was performed.
The first evaluation (induction exposure, nonspecific irritation) of the skin reaction was made 1 hour after the intradermal injection of the substance, and the second 24 hours.
TOPICAL APPLICATION: To assess a possible local skin reaction a patch test procedure was conducted in the following week (7 days after the first application) on the back of the same animals.
Therefore, 2 mL of 20% preparation of the test substance was applied on an approximately 30 cm² of plastic film, covered by a rubberised bandage and attached between the front and hind limbs on the intact and shaved skin of the back of animals. The gauze-patch remained on the skin fixed for 48 hours. 24 hours after removing the patch the 3rd assessment of skin reaction was performed.
B. CHALLENGE EXPOSURE
In order to evaluate the possible sensitizing properties of 1,2,4-trichlorobenzene, a further dermal treatment (patch test procedure as described above) was conducted 2 weeks after the percutaneous exposure on both flanks of animals.
The piece of tissue with the test substance was placed on the left flank, the one with the vehicle on the right flank.
The fourth assessment of the skin reaction was performed 24 hours after the removal of the patches. Changes, provoked by the bandage, were by that time faded away. The fifth assessment was made after 48 hours after the removal of the patch. - Challenge controls:
- no data
- Positive control substance(s):
- yes
- Remarks:
- 5000IE/0.1 mL Penicillin G-Na
- Positive control results:
- 20 animals were used as positive control group in the main test. The degree of sensitization was V, so that in this control experiment Penicillin G-Na was classified as extreme
- Reading:
- other: mean value of two readings
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- not reported
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Clinical observations:
- not reported
- Remarks on result:
- other: Reading: other: mean value of two readings. . Hours after challenge: 72.0. Group: test group. Dose level: not reported. No with. + reactions: 2.0. Total no. in groups: 20.0.
- Interpretation of results:
- GHS criteria not met
- Executive summary:
Korte & Greim (1981)
A guinea-pig maximisation study according to OECD TG 406 with deviations ( No GLP. No information on any negative control group, or the concentration of 1,2,4-TCB. Occlusive bandage during epicutaneous exposure. Detailed results are not reported). In general, substances were tested in this study at concentrations of 0.5-10%.
1,2,4-TCB resulted in a positive reaction in <10% of the animals.
These results indicate only a weak sensitisation potential and the classification of 1,2,4-TCB for skin sensitisation is not required according to the GHS classification criteria.
Referenceopen allclose all
Table 7.4.1/1: Reactions on intact Guinea Pig Skin
| Test animals | Control animals | ||
Concentration (% in f.a.d.) | 75% | 95% | 75% | 95% |
Primary irritation test – 24 hrs | 4+, 6 neg. | 4+, 6 neg. | - | - |
Challenge test – 24 hrs | 3+++, 7+++ | 4+++, 6++ | 3+++, 7++ | 3+++, 7++ |
EU Risk Assessment (2003):
Some studies on sensitisation are summarized in EU Risk Assessment.
Some of these studies were reliable studies with restrictions or reliability was not assignable because references were only cited as secondary literature.
In one study (Brown et al., 1969) guinea pigs were exposed subcutaneously and open epicutaneously to 0.1% w/v of 98% pure 1,2,4-TCB in light liquid paraffin to the shorn skin on the back of the guinea pigs on 3 days in each of three successive weeks. The animals then received no treatment for 10 days and a challenge dose of the same solution on the right flank and of solvent on the left flank on the eleventh day. Following the challenge the animals were examined at 1 hour, 24 hours and 48 hours for signs of sensitisation reaction. The test result was negative. The test was repeated with the same animals and also gave a negative result.
Tested in guinea pigs by Haskell Laboratories by applying 1,2,4-TCB either topically 9 times over a three week period, or by intradermal injection 4 times over the same period, and challenged by dermal application after a two-week rest period, the animals showed no sign of sensitisation (Du Pont de Nemours, 1971b). However (as described above under skin irritation) both treated and control animals showed signs of skin irritation after the challenge.
1,2,4-TCB resulted in a positive reaction in <10% of the animals. Detailed test results are not available.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
Skin sensitisation:
A GPMT study performed according to OECD TG 406 resulted in < 10% sensitization rate (2/20 animals) (Korte and Greim, 1981). Two other assays reported also negative results (Brown et al., 1969 & Du Pont de Nemours, 1969).
According to the EU RAR, all the studies available suffer from various forms of deficiencies and as a result, the database for this effect is limited. However, these results indicate only a weak sensitisation potential and the classification of 1,2,4-TCB for skin sensitisation is not required.
Justification for classification or non-classification
Harmonised classification:
The substance has no harmonised classification according to the Regulation (EC) No. 1272/2008 (CLP).
Self classification:
Based on the available information no additional self-classification is proposed according to the CLP and the GHS.
No information is available regarding respiratory sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.